Ayers and colleagues demonstrated how an inflamed T-cell gene expression signature significantly predicted response to CPI therapy in multiple types of cancer, independently of both PD-L1 status and TMB (9, 10), suggesting that tumor suppression of infiltrating immune cells may represent a discrete mechanism of immune evasion. This evidence concerns the gene CD274 and neoplasm.